Helus Pharma Inc. Common Stock (HELP) News

Latest headlines that mention HELP, newest first · each headline opens the original publisher

HELP quote

Last price: $10.36
Day change: +1.67%
Next earnings: 2026-11-12

Quote & chart Expected move Insider trading IV rank history

HELP headlines

latest coverage

Seeking Alpha News 3d ago

Helus Pharma Inc. (HELP) Discusses Clinical Pipeline and Phase 3 Strategies for Novel Serotonergic Agonists in Mental Health - Slideshow

General T2HELP

Seeking Alpha News 5d ago

Helus Pharma Inc. (HELP) Discusses Clinical Pipeline and Phase 3 Strategies for Novel Serotonergic Agonists in Mental Health Transcript

General T2HELP

Seeking Alpha News 15d ago

Helus Pharma: A Buy Ahead Of The HLP003 Phase 3 Readout

General T2HELP

Investing.com 1mo ago

Helus Pharma shareholders approve name change from Cybin Inc.

General T3HELP

Seeking Alpha News 1mo ago

Cybin Inc. (HELP) Shareholder/Analyst Call Prepared Remarks Transcript

General T2HELP

Yahoo Finance 1mo ago

Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Board

General T2HELP

Seeking Alpha News 1mo ago

Cybin Inc. (HELP) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

General T2HELP

Seeking Alpha 2mo ago

Cybin reports Q1 results

Earnings T2HELP

Yahoo Finance 3mo ago

Is Cybin D/B/A Helus Pharma (HELP) Stock a Psychedelic Medicine Opportunity Ahead of HLP003 Trial Results?

General T2HELP

Seeking Alpha News 4mo ago

Cybin: A Speculative Bet On Their Pivotal Depression Readout

General T2HELP

HELP news alerts

Get an alert by email or push when a new headline mentions HELP.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.